Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed a press release dated October 10, 2024, titled ‘Pharma leaders drive conversations on GenAI, technology transformation and commercialization strategy at Indegene Digital Summit, October 17-18, 2024, Virtual-only’. The above information will be made available on the website of the Company: https://www.indegene.com/. A copy of the Press Release is enclosed.
The above information is a part of company’s filings submitted to BSE.
